Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
6.15
+0.22 (3.71%)
Dec 20, 2024, 4:00 PM EST - Market closed
Pulmonx Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Pulmonx stock have an average target of 11.92, with a low estimate of 7.50 and a high estimate of 16. The average target predicts an increase of 93.82% from the current stock price of 6.15.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Pulmonx stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wells Fargo | Wells Fargo | Hold Maintains $10 → $8 | Hold | Maintains | $10 → $8 | +30.08% | Dec 11, 2024 |
| Citigroup | Citigroup | Strong Buy → Hold Downgrades $17 → $7.5 | Strong Buy → Hold | Downgrades | $17 → $7.5 | +21.95% | Dec 11, 2024 |
| Stifel | Stifel | Strong Buy Maintains $17 → $16 | Strong Buy | Maintains | $17 → $16 | +160.16% | Oct 31, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $14 → $12 | Buy | Maintains | $14 → $12 | +95.12% | Aug 1, 2024 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $15 → $16 | Strong Buy | Maintains | $15 → $16 | +160.16% | Aug 1, 2024 |
Financial Forecast
Revenue This Year
83.96M
from 68.68M
Increased by 22.26%
Revenue Next Year
99.68M
from 83.96M
Increased by 18.72%
EPS This Year
-1.59
from -1.60
EPS Next Year
-1.63
from -1.59
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 87.0M | 104.7M | 127.0M | |||
| Avg | 84.0M | 99.7M | 119.6M | |||
| Low | 79.9M | 93.6M | 112.5M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | 26.6% | 24.7% | 27.4% | |||
| Avg | 22.3% | 18.7% | 19.9% | |||
| Low | 16.3% | 11.5% | 12.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | -1.60 | -1.50 | -1.21 | |||
| Avg | -1.59 | -1.63 | -1.39 | |||
| Low | -1.55 | -1.77 | -1.59 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|---|
| High | - | - | - | |||
| Avg | - | - | - | |||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.